Frost & Sullivan: Live Cell Imaging Revolutionises Disease Diagnostics and Drug Discovery

Description

Frost & Sullivan: Live Cell ImagingFrost & Sullivan: Live Cell Imaging Revolutionises Disease Diagnostics and Drug Discovery PR Newswire LONDON, March 19, 2014 -- Stakeholder collaboration will be crucial to convert these developments into clinically meaningful tests Tremendous advances in electronics, optics, fluorescent tools, and molecular biology have made live cell imaging technologies more accessible to life scientists looking to understand biological dynamics and visualize cellular events in organisms. The foray of omics technologies and nanotechnologies into mainstream medicine has already enabled commercial lab-on-a-chip microfluidics systems that analyse cells, DNA, RNA and proteins. As live cell imaging evolves, it will become an integral part of disease diagnostics and drug discovery processes. New analysis from Frost & Sullivan, The Untapped Potential in Live Cell Imaging, finds that live cell imaging technologies will have a large number of niche applications in cell biology, cancer research, developmental biology and neuroscience. Currently available technologies include live cell based tests systems and molecular models such as high resolution imaging systems. "The principal challenges to successful live cell imaging are microscopic settings optimization, fluorescent components selection, and culture environment maintenance," said Technical Insights Senior Research Analyst Cecilia Van Cauwenberghe.

Subjects

• Documents
• Actualité et débat de société
• Media

Informations

• Published by: frost-sullivan
• Published: 19 March 2014
• Reads: 3
• Language: English